BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for MODERNA US INC. · Pharmaceuticals

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · Senate · $80,000.00 income · posted Jul 18, 2025

Lobbying activity 1

Health Issues

Issues related to drug discovery, drug development, vaccine technologies, and coverage and reimbursement Issues related to biotechnology legislation and supply chain

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.